KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Cash from Investing Activities (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Cash from Investing Activities for 13 consecutive years, with $62.7 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 36.35% to $62.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $218.0 million through Dec 2025, up 32.12% year-over-year, with the annual reading at $218.0 million for FY2025, 32.12% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $62.7 million at Xenon Pharmaceuticals, up from $38.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $109.2 million in Q2 2024, with the low at -$239.8 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$13.4 million, with a median of $11.9 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities tumbled 1943.03% in 2023, then soared 7637.15% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$215.4 million in 2021, then surged by 94.55% to -$11.7 million in 2022, then crashed by 1943.03% to -$239.8 million in 2023, then soared by 141.08% to $98.5 million in 2024, then plummeted by 36.35% to $62.7 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $62.7 million, $38.5 million, and $82.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.